
Sign up to save your podcasts
Or


Explore Roche's strategic dual-pillar model and how its pharmaceutical and diagnostics businesses fuel a robust recovery. Uncover scientific innovations shaping its future pipeline and key financial metrics that signal durable growth and investment potential.
By Softgate CapitalExplore Roche's strategic dual-pillar model and how its pharmaceutical and diagnostics businesses fuel a robust recovery. Uncover scientific innovations shaping its future pipeline and key financial metrics that signal durable growth and investment potential.